Abstract: Film-formation-type antifungal preparations for external application, consisting essentially of about 0.1% to about 1.5% of tolnaphtate, about 10% to about 20% of a dimethylaminoethyl methacrylate-methacrylic acid ester copolymer and 0.5% to about 10% of a medium chain fatty acid ester in an alcoholic solvent but containing practically no water.

Abstract: A granular pharmaceutical composition containing 85 to 99 percent ibuprofen, 0.9 to 15.0 percent binder, and 0.1 to 5.0 percent polyvinylpyrrolidone, wherein the polyvinylpyrrolidone forms a film with a portion of said binder to form agglomerates, is disclosed. Ibuprofen may be fluidized with a portion of the binder in a fluid bed apparatus and sprayed with an aqueous dispersion of polyvinylpyrrolidone and the remainder of the binder. This granulation may be subsequently blended with additional excipients and, optionally, additional active pharmaceutical ingredients for direct compression into tablets.

Abstract: A bone cement is disclosed wherein the liquid component contains a therapeutic or diagnostic substance in combination with an emulsifying agent for said substance.

Abstract: There is disclosed, in one aspect, a composition for forming a protective barrier while disinfecting substrates such as human or animal skin. The composition comprises two gels adapted to be simultaneously applied and mixed in situ and to adhere onto the substrate. The first gel comprises an aqueous solution containing suitable amounts of a protic acid, preferably lactic acid. The second gel comprises an amount of a metal chlorite such as sodium chlorite, such that the chlorite ion concentration in the form of chlorous acid in the combined gels is no more than about 15% by weight of the total amount of chlorite ion concentration. The second gel also contains a polysulfonic acid salt. The anion of that salt has the formula: ##STR1## wherein X has a value such that the molecular weight of the anionic portion of the polymer is from about 1,000,000 to about 5,000,000. In another aspect, there is disclosed a method for treating skin diseases.

Abstract: Pesticidal 5-ethynyl substituted thizoles, compositions thereof and use thereof as insecticides and miticides are disclosed and exemplified.

Abstract: An aseptic package of a material susceptible to bacterial or viral infection utilizes a film or sheet of a plastic packaging material having a biocidal agent dissolved or dispersed therein. The biocidal agent comprises 10,10-oxybisphenoxarsine or a biocidal derivative or analog thereof, in an amount sufficient to inhibit biocidal activity in the contents of the package. The biocidal agent is present in solution in or in combination with a plasticizer for the plastic sheet or film in an amount from 0.001 to 5.0% by weight of the plastic. The sheet or film is a hydrocarbon-based material, such as a polyalkylene resin or polyolefin, e.g., polyethylene or polypropylene. The biocidal agent is present in solution in or in combination with a plasticizer for the plastic sheet or film. The enclosed material may be an organic product, such as a food or a plant or may be formed in the shape of a dispensible liner for bath tubs.

Abstract: There is provided a stable, ophthalmic aqueous composition for topical administration, comprising (a) acetazolamide and either (b) a pre-formed, pharmaceutically acceptable, aqueous gel or (c) an aqueous gel-forming liquid capable of forming a pharmaceutically acceptable gel in situ when applied topically to a patient; said composition having a pH of less than 5.0.

Abstract: Heat-vulcanized silicone dosage forms adapted for the continuous and controlled release of iodine values, notably to domestic water supplies for the treatment of the various disease states attributed to iodine deficiency, are shaped from (A) a diorganopolysiloxane matrix resin containing at least two vinyl groups bonded to silicon per molecule and having a viscosity of at least 500,000 mPa.s at 25.degree. C.; (B) at least one organohydropolysiloxane containing at least three hydrogen atoms bonded to silicon per molecule; (C) a reinforcing amount of a filler material therefor; (D) a catalytically effective amount of a platinum group metal catalyst; and (E) a therapeutically effective amount of at least one water soluble, nontoxic, organic and/or inorganic iodine compound which is in solid or liquid state at ambient temperature.

Abstract: Gel bases for pharmaceutical compositions comprise from about 0.5 to about 10.0% by weight ethoxylated (2 to 30 moles of ethoxylation) behenyl alcohol and from about 90 to 99.5% of a glycol solvent or from about 2.5 to about 10.0% by weight ethoxylated fatty alcohols having a chain length of from 16 to 21 carbon atoms and from 90 to about 97.5% of a glycol solvent. Preferred glycol solvents include propylene glycol and polyethylent glycols having an average molecular weight of about 200 to 800. Pharmaceutical compositions suitable for topical, transmucosal and oral administration may be prepared utilizing the novel gel bases. Methods of administration of topically, systemically and orally active pharmaceutical agents utilizing the novel gel bases are also provided.

Abstract: A pharmaceutical preparation contains an active ingredient added to polyalcohols, such as polyethylene and/or polyalkylene glycols and/or oxystearates of glycerine-polyethyleneglycol and/or partial fatty acid esters of sorbitan or polyhydroxyethylenesorbitan and/or polyvinylpyrrolidone and/or polyvinylalcohols and/or fatty alcohol ethers of polyhydroxyethylene or fatty acid ester of polyhydroxyethylene and/or condensates of polyhydroxyethylene-polyhydroxypropylene, and especially dissolved in nifedipine in a weight ratio between 1:2 and 1:25. The composition contains ethanol as well, in an amount ratio between 1:25 and 1:4 of nifedipine:ethanol and can be sprayed with a propeller gas.

Abstract: A novel elastomeric composition of matter comprises a rubber latex and a masterbatch comprising a therapeutic agent in a therapeutically effective amount, a carrier component, titanium dioxide, and clay. A process for the preparation of a novel elastomeric composition of matter containing a therapeutic agent includes the steps of preparing a masterbatch containing a therapeutic agent, adding the masterbatch to a rubber latex and thereafter forming and curing a desired product therefrom. The composition is useful in the manufacture of rubber goods such as surgical and medical products which can be single or multilayered.

Abstract: A therapeutic method of treating the chronic human superficial fungus infection tinea pedis produced by the pathogenic dermatophytic fungi Microsporum sp., Trichophyton sp., and Epidermophyton sp., which invade and attack keratinized skin areas of the body by repeatedly applying topically to the itching, macerated, cracked, and scaling skin areas of the body at the site of the infection a fungicidally effective amount of a silane-containing lotion antagonistic to the dermatophytic fungi in order to exert at least an inhibitory growth effect upon the dermatophytes.